# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-006429
Filing Date
2025-04-28
Accepted
2025-04-28 16:15:23
Documents
21
Period of Report
2025-04-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | formdef14a.htm iXBRL | DEF 14A | 686206
2 | GRAPHIC | def14a_001.jpg | GRAPHIC | 11258
3 | GRAPHIC | def14a_002.jpg | GRAPHIC | 56691
4 | GRAPHIC | def14a_003.jpg | GRAPHIC | 26757
5 | GRAPHIC | proxy_001.jpg | GRAPHIC | 831653
6 | GRAPHIC | proxy_002.jpg | GRAPHIC | 682944
| Complete submission text file | 0001641172-25-006429.txt |  | 4930217

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | indp-20241231.xsd | EX-101.SCH | 5219
8 | XBRL DEFINITION FILE | indp-20241231_def.xml | EX-101.DEF | 9261
9 | XBRL LABEL FILE | indp-20241231_lab.xml | EX-101.LAB | 57743
10 | XBRL PRESENTATION FILE | indp-20241231_pre.xml | EX-101.PRE | 41850
23 | EXTRACTED XBRL INSTANCE DOCUMENT | formdef14a_htm.xml | XML | 53049

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40652 | Film No.: 25880548
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)